Suchergebnisse - "Ebbo, Mikael"

PubPharm (7)

1

Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia : Results at 5 years from the French prospective registry ITP-ritux

enthalten in: American journal of hematology | 2019

von Deshayes, S. | Khellaf, M. | Zarour, A. | +22

2

A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study)

enthalten in: American journal of hematology | 2017

von Michel, M. | Terriou, L. | Roudot-Thoraval, F. | +12

3

Long-term efficacy and safety of rituximab in IgG4-related disease : Data from a French nationwide study of thirty-three patients

enthalten in: PloS one | 2017

von Ebbo, M. | Grados, A. | Samson, M. | +26

4

Safety and efficacy of rituximab in adult immune thrombocytopenia : results from a prospective registry including 248 patients

enthalten in: Blood | 2014

von Khellaf, M. | Charles-Nelson, A. | Fain, O. | +22

5

Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease : a retrospective multicenter study

enthalten in: Arthritis care & research | 2014

von Ebbo, M. | Grados, A. | Guedj, E. | +18

6

Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia

enthalten in: American journal of hematology | 2013

von Mahévas, M. | Ebbo, M. | Audia, S. | +9

7

B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells

enthalten in: The Journal of clinical investigation | 2013

von Mahévas, M. | Patin, P. | Huetz, F. | +16

1
[1]